lncRNAs as prognostic markers and therapeutic targets in cuproptosis-mediated cancer
Clinical and Experimental Medicine,
Journal Year:
2024,
Volume and Issue:
24(1)
Published: Sept. 26, 2024
Abstract
Long
non-coding
RNAs
(lncRNAs)
have
emerged
as
crucial
regulators
in
various
cellular
processes,
including
cancer
progression
and
stress
response.
Recent
studies
demonstrated
that
copper
accumulation
induces
a
unique
form
of
cell
death
known
cuproptosis,
with
lncRNAs
playing
key
role
regulating
cuproptosis-associated
pathways.
These
may
trigger
cell-specific
responses
to
stress,
presenting
new
opportunities
prognostic
markers
therapeutic
targets.
This
paper
delves
into
the
cuproptosis-mediated
cancer,
underscoring
their
potential
biomarkers
targets
for
innovative
strategies.
A
thorough
review
scientific
literature
was
conducted,
utilizing
databases
such
PubMed,
Google
Scholar,
ScienceDirect,
search
terms
like
'lncRNAs,'
'cuproptosis,'
'cancer.'
Studies
were
selected
based
on
relevance
lncRNA
regulation
cuproptosis
pathways
implications
prognosis
treatment.
The
highlights
significant
contribution
cuproptosis-related
genes
pathways,
impacting
metabolism,
mitochondrial
responses,
apoptotic
signaling.
Specific
are
breast,
lung,
liver,
ovarian,
pancreatic,
gastric
cancers.
objective
this
article
is
explore
cancers
mediated
by
cuproptosis.
Language: Английский
Harnessing nanomaterials for copper-induced cell death
Su-Ran Li,
No information about this author
Shi-Yue Tao,
No information about this author
Qian Li
No information about this author
et al.
Biomaterials,
Journal Year:
2024,
Volume and Issue:
313, P. 122805 - 122805
Published: Sept. 3, 2024
Language: Английский
Long Non-Coding RNAs in Drug Resistance of Gastric Cancer: Complex Mechanisms and Potential Clinical Applications
Xiangyu Meng,
No information about this author
Xiao Bai,
No information about this author
Angting Ke
No information about this author
et al.
Biomolecules,
Journal Year:
2024,
Volume and Issue:
14(6), P. 608 - 608
Published: May 22, 2024
Gastric
cancer
(GC)
ranks
as
the
third
most
prevalent
malignancy
and
a
leading
cause
of
cancer-related
mortality
worldwide.
However,
majority
patients
with
GC
are
diagnosed
at
an
advanced
stage,
highlighting
urgent
need
for
effective
perioperative
postoperative
chemotherapy
to
prevent
relapse
metastasis.
The
current
treatment
strategies
have
limited
overall
efficacy
because
intrinsic
or
acquired
drug
resistance.
Recent
evidence
suggests
that
dysregulated
long
non-coding
RNAs
(lncRNAs)
play
significant
role
in
mediating
resistance
GC.
Therefore,
there
is
imperative
explore
novel
molecular
mechanisms
underlying
order
overcome
this
challenging
issue.
With
advancements
deep
transcriptome
sequencing
technology,
lncRNAs—once
considered
transcriptional
noise—have
garnered
widespread
attention
potential
regulators
carcinogenesis,
including
tumor
cell
proliferation,
metastasis,
sensitivity
chemo-
radiotherapy
through
multiple
regulatory
mechanisms.
In
light
these
findings,
we
aim
review
by
which
lncRNAs
contribute
therapy
goal
providing
new
insights
breakthroughs
toward
overcoming
formidable
obstacle.
Language: Английский
The functions of cuproptosis in gastric cancer: therapy, diagnosis, prognosis
Zhiqin Zhang,
No information about this author
Shenhua Shao,
No information about this author
Hao Luo
No information about this author
et al.
Biomedicine & Pharmacotherapy,
Journal Year:
2024,
Volume and Issue:
177, P. 117100 - 117100
Published: July 15, 2024
Gastric
cancer
(GC)
is
the
fifth
most
prevalent
type
of
in
whole
world.
Cuproptosis
discovered
as
a
programmed
cell
death
pathway
and
connected
to
cells'
growth
death,
well
tumorigenesis.
The
relationship
between
cuproptosis
GC
still
elusive.
Two
aspects
this
study
will
elaborate
immunotherapy
biomarkers
GC.
Notably,
herein
review
intended
highlight
what
has
been
accomplished
regarding
for
diagnosis,
immunotherapy,
prognosis
aim
offer
potential
directions
strategies
future
research
inside
Language: Английский
Construction of a cuproptosis‑related lncRNA signature to predict biochemical recurrence of prostate cancer
Zhaojun Yu,
No information about this author
Huanhuan Deng,
No information about this author
Haichao Chao
No information about this author
et al.
Oncology Letters,
Journal Year:
2024,
Volume and Issue:
28(5)
Published: Sept. 3, 2024
Biochemical
recurrence
(BCR)
is
common
in
prostate
cancer
(PCa),
and
patients
with
BCR
usually
have
a
poor
prognosis.
Cuproptosis
unique
type
of
cell
death,
copper
homeostasis
crucial
to
the
occurrence
development
malignancies.
The
present
study
aimed
explore
prognostic
value
cuproptosis‑related
long
non‑coding
RNAs
(lncRNAs;
CRLs)
PCa
develop
predictive
signature
for
forecasting
PCa.
Using
Cancer
Genome
Atlas
database,
transcriptomic,
mutation
clinical
data
were
collected
from
A
total
121
CRLs
identified
using
Pearson's
correlation
coefficient.
Subsequently,
6‑CRL
consisting
AC087276.2,
CNNM3‑DT,
AC090198.1,
AC138207.5,
METTL14‑DT
LINC01515
was
created
predict
through
Cox
least
absolute
shrinkage
selection
operator
regression
analyses.
Kaplan‑Meier
curve
analysis
demonstrated
that
high‑risk
had
low
BCR‑free
survival
rate.
In
addition,
there
substantial
difference
between
high‑
low‑risk
groups
immune
microenvironment,
therapy,
drug
sensitivity
tumor
mutational
burden.
nomogram
integrating
Gleason
score,
T‑stage
established
evaluated.
Finally,
expression
lncRNAs
cells
verified
reverse
transcription‑quantitative
PCR.
conclusion,
may
be
potential
tool
making
predictions
regarding
PCa,
considered
practical
decision‑making.
Language: Английский
Study on the role and pharmacology of cuproptosis in gastric cancer
Lin Jiang,
No information about this author
Junzuo Liao,
No information about this author
Yunwei Han
No information about this author
et al.
Frontiers in Oncology,
Journal Year:
2023,
Volume and Issue:
13
Published: March 17, 2023
Gastric
cancer
has
a
poor
prognosis
and
high
mortality.
Cuproptosis,
novel
programmed
cell
death,
is
rarely
studied
in
gastric
cancer.
Studying
the
mechanism
of
cuproptosis
conducive
to
development
new
drugs,
improving
patients
reducing
burden
disease.The
TCGA
database
was
used
obtain
transcriptome
data
from
tissues
adjacent
tissues.
GSE66229
for
external
verification.
Overlapping
genes
were
obtained
by
crossing
differential
analysis
with
those
related
copper
death.
Eight
characteristic
three
dimensionality
reduction
methods:
lasso,
SVM,
random
forest.
ROC
nomogram
estimate
diagnostic
efficacy
genes.
The
CIBERSORT
method
assess
immune
infiltration.
ConsensusClusterPlus
subtype
classification.
Discovery
Studio
software
conducts
molecular
docking
between
drugs
target
proteins.We
have
established
early
diagnosis
model
eight
(ENTPD3,
PDZD4,
CNN1,
GTPBP4,
FPGS,
UTP25,
CENPW,
FAM111A)
results
are
validated
internal
data,
predictive
power
good.
classification
type
samples
performed
based
on
consensus
clustering
method.
We
identified
C2
as
an
C1
non-immune
subtype.
Small
molecule
drug
targeting
associated
predicts
potential
therapeutics
Molecular
revealed
multiple
forces
Dasatinib
CNN1.The
candidate
may
be
effective
treating
affecting
expression
signature
gene.
Language: Английский
Dual identity of tumor-associated macrophage in regulated cell death and oncotherapy
Yingying Shao,
No information about this author
Yu Wang,
No information about this author
Ranran Su
No information about this author
et al.
Heliyon,
Journal Year:
2023,
Volume and Issue:
9(7), P. e17582 - e17582
Published: June 26, 2023
Tumor-associated
macrophage
(TAM)
affects
the
intrinsic
properties
of
tumor
cells
and
microenvironment
(TME),
which
can
stimulate
cell
proliferation,
migration,
genetic
instability,
diversity
includes
tumors
with
different
functional
characteristics.
Macrophages
are
now
a
central
drug
target
in
various
diseases,
especially
TME,
which,
as
"tumor
promoters"
"immunosuppressors",
have
responsibilities
during
development
accompany
by
significant
dynamic
alterations
subpopulations.
Remodelling
immunosuppression
TME
promotion
pre-existing
antitumor
immune
responses
is
critical
altering
TAM
polarization,
relevant
to
efficacy
immunotherapy,
uncovering
exact
mechanism
action
TAMs
identifying
their
specific
targets
vital
optimizing
current
immunotherapies.
Hence,
this
review
aims
reveal
triadic
interactions
macrophages
programmed
death
oncotherapy,
integrate
certain
relationships
cancer
treatment.
Language: Английский
A New Cuproptosis-Related lncRNAs Model for Predicting the Prognosis of Hepatitis B Virus-Associated Hepatocellular Carcinoma and Experimental Validation of LINC01269
Chuanbing Shi,
No information about this author
Yintao Sun,
No information about this author
Ling Sha
No information about this author
et al.
International Journal of General Medicine,
Journal Year:
2024,
Volume and Issue:
Volume 17, P. 6009 - 6027
Published: Dec. 1, 2024
Hepatocellular
carcinoma
(HCC)
triggered
by
Hepatitis
B
virus
(HBV)
remains
a
significant
clinical
challenge,
necessitating
novel
therapeutic
interventions.
Copper
ionophores,
recognized
for
introducing
an
innovative
type
of
programmed
cell
death
termed
cuproptosis,
present
promising
potentials
cancer
therapy.
Nevertheless,
The
role
cuproptosis-related
lncRNAs
(CRLRs)
in
HBV-HCC
has
not
been
clearly
elucidated.
This
study
utilised
univariate
Cox,
least
absolute
shrinkage
and
selection
operator
(LASSO),
multivariable
Cox
regression
analyses
to
establish
signature
CRLRs
HBV-HCC.
prognostic
model
was
validated
with
independent
internal
validation
cohort,
combined
parameters,
used
construct
nomogram
patient
survival
predictions.
Gene
Ontology
(GO)
Set
Enrichment
Analysis
(GSEA)
were
employed
explore
associated
biological
pathways.
Additionally,
protein-protein
interaction
(PPI)
network
developed,
implications
tumour
mutational
burden
(TMB)
drug
response
examined.
A
comprehensive
bioinformatics
analysis
these
hub
performed,
followed
experimental
through
quantitative
real-time
PCR
(qRT-PCR)
functional
cellular
assays.
showed
high
predictive
accuracy
survival.
GO
GSEA
indicated
that
are
involved
pathways
related
oestrogen
metabolism.
PPI
consisting
201
nodes
568
edges
the
TMB
differed
significantly
between
high-
low-risk
groups.
Analyses
identified
three
CRLRs,
SOS1-IT1,
AC104695.3,
LINC01269,
which
differentially
expressed
HCC
tissues.
In
vitro,
LINC01269
found
enhance
proliferation,
invasion,
migration.
first
systematic
exploration
roles
demonstrates
their
critical
involvement
disease's
pathogenesis
possible
implication.
distinct
expression
patterns
suggest
may
facilitate
targets.
Language: Английский